![Robin Sherrington](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robin Sherrington
Corporate Officer/Principal chez XENON PHARMACEUTICALS INC.
Fortune : 327 438 $ au 30/06/2024
Profil
Robin Sherrington is currently the Executive Vice President-Strategy & Innovation at Xenon Pharmaceuticals, Inc. He previously worked as a Neuroscience Director at Pfizer Inc., Sequana Therapeutics, Inc., and Axys Pharmaceuticals, Inc. He also worked as a Neuroscientist at Parke-Davis & Co. Ltd.
Dr. Sherrington completed his undergraduate degree at The University of Reading and holds a doctorate degree from University College London.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
05/04/2024 | 8 398 ( 0,01% ) | 327 438 $ | 30/06/2024 |
Postes actifs de Robin Sherrington
Sociétés | Poste | Début |
---|---|---|
XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/03/2019 |
Anciens postes connus de Robin Sherrington
Sociétés | Poste | Fin |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01/01/2001 |
Axys Pharmaceuticals, Inc.
![]() Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1999 |
Sequana Therapeutics, Inc.
![]() Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Corporate Officer/Principal | 01/01/1999 |
Parke-Davis & Co. Ltd.
![]() Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Corporate Officer/Principal | - |
Formation de Robin Sherrington
University College London | Doctorate Degree |
The University of Reading | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
XENON PHARMACEUTICALS INC. | Health Technology |
PFIZER, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Axys Pharmaceuticals, Inc.
![]() Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Sequana Therapeutics, Inc.
![]() Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
Parke-Davis & Co. Ltd.
![]() Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |